Strategic Analysis of Opportunities in the CRO Market - Phase 0

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This strategic analysis study attempts to understand the opportunities for contract research organisations and pharmaceutical companies to take advantage of the inevitable choice of Phase zero or Microdosing studies in the drug development process. The background of microdosing, industry challenges, regulatory guidelines and competitive analysis are discussed in detail.

Table of Contents

Strategic Analysis of Opportunities in the CRO Market - Phase 0, Research MethodologyResearch ProcessScope and ObjectiveStrategic Analysis of Opportunities in the CRO Market - Phase 0, Industry ChallengesChallenges Faced by the CROsConsolidation within the CRO Industry to Threaten Customer RelationshipElectronic Data Capture Threatens RevenuesRisk Sharing Model Necessitates Proper Positioning of ServicesRegional Disparities Affect Competitive Pricing of ServicesStrategic Analysis of Opportunities in the CRO Market - Phase 0, Market OverviewPhase ZeroCRO Contribution to Drug DevelopmentHuman MicrodosingTechnologies Used in MicrodosingAdvantages of MicrodosingFDA and EMEA RegulationsThe EUMAPP ProgramConcerns about MicrodosingRevenue Forecasts Future OutlookProfiles of Key Industry ParticipantsAccium BiosciencesRadiant ResearchVitalea ScienceXceleronStrategic Analysis of Opportunities in the CRO Market - Phase 0, Strategic RecommendationsApproaches to MicrodosingAlternative Applications of MicrodosingStrategic Analysis of Opportunities in the CRO Market - Phase 0, Decision Support DatabasesDSD TablesNumber of Biotech CompaniesGovernment R&D Expenditure in BiotechnologyPer cent Government Biotech R&D InvestmentPharmaceutical R&D ExpenditurePer cent R&D Pharmaceutical Expenditure




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.